Tertiary container - antiblastic medicines - Esamed

Tertiary container - antiblastic medicines - Esamed

4.7
(780)
Scrivi Recensione
Di più
€ 20.99
Nel carrello
In Magazzino
Descrizione

Clinical Trials See Boxed Warning for TRIUMEQ (abacavir, dolutegravir, lamivudine)

Tertiary container - antiblastic medicines - Esamed

Blocking Reagent – UltraCruz®

First evidence of anticancer and antimicrobial activity in Mediterranean mesopelagic species

Frontiers Dissecting Drug-Induced Cytotoxicity and Metabolic Dysfunction in Conditionally Immortalized Human Proximal Tubule Cells

Clinical, DuoClick™ Containers

Telcagepant - an overview

Avapritinib: A Selective Inhibitor of KIT and PDGFRα that Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell Lines

Ideal for use in harsh transport conditions or in pneumatic tube systems

Starplex™ Scientific LeakBuster™ Specimen Containers: Sterile